These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 5127448)

  • 21. [Unwanted drug effects on the gastrointestinal tract].
    Börsch G; Ricken D
    Dtsch Med Wochenschr; 1989 Feb; 114(5):184-7. PubMed ID: 2644117
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical effect of Intensain for ischemic heart disease].
    Imura R; Iyanaga T; Baba K; Hirose T; Mihara T
    Nihon Rinsho; 1968 May; 26(5):1288-90. PubMed ID: 5749810
    [No Abstract]   [Full Text] [Related]  

  • 23. [Prolonged coronary insufficiency and anticoagulant therapy].
    Recalcati P; Ballarino M
    Cardiol Prat; 1967 Aug; 18(4):9-28. PubMed ID: 5608439
    [No Abstract]   [Full Text] [Related]  

  • 24. [On the treatment of coronary insufficiency].
    Pezzana A; Maltoni N
    Minerva Cardioangiol; 1967 Jan; 15(1):50-7. PubMed ID: 5597264
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of preoperative preparation with neomycin (colimycin) on the function of gastrointestinal tract].
    Morozov EF
    Antibiotiki; 1966 Dec; 11(12):1127-32. PubMed ID: 5997609
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hepato-digestive tolerance to prothionamide].
    Lesorbre R; Delacoux E; Frey N; Wilmotte F; Legrand M
    Ann Biol Clin (Paris); 1968; 26(5):681-8. PubMed ID: 5681857
    [No Abstract]   [Full Text] [Related]  

  • 27. The effects of carbochromen on myocardial blood flow and metabolic heat production before and after acute coronary ligation.
    Grayson J; Irvine M; Parratt JR
    Br J Pharmacol; 1969 Oct; 37(2):523P-524P. PubMed ID: 5348445
    [No Abstract]   [Full Text] [Related]  

  • 28. Drug damage and the gastrointestinal tract.
    Palmer ED
    Mil Med; 1973 Jan; 138(1):38. PubMed ID: 4630057
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical evaluation of intensain--coronary vasodilator agent].
    Hruczkowska E; Korolko A
    Pol Tyg Lek; 1969 Jun; 24(26):1012-3. PubMed ID: 5805068
    [No Abstract]   [Full Text] [Related]  

  • 30. [Anticoagulant treatment and digestive hemorrhages].
    Himbert J; Sée E; Thiroloix P; Lenègre J
    Ann Med Interne (Paris); 1971 Nov; 122(11):1055-64. PubMed ID: 5317109
    [No Abstract]   [Full Text] [Related]  

  • 31. [Therapy of severe coronary insufficiency with Intensain].
    Friese G; Eisenbarth D
    Med Welt; 1968 Sep; 36():1896-904. PubMed ID: 5716633
    [No Abstract]   [Full Text] [Related]  

  • 32. Aspirin and coronary artery diseases.
    Jauhari J
    J Indian Med Assoc; 1993 Mar; 91(3):50-1. PubMed ID: 8349998
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of heart and coronary insufficiency with Intensain Lanicor].
    Kligge H
    Munch Med Wochenschr; 1966 May; 108(21):1169-76. PubMed ID: 6014174
    [No Abstract]   [Full Text] [Related]  

  • 34. A possible mechanism of gastrointestinal toxicity posed by mycophenolic acid.
    Neerman MF; Boothe DM
    Pharmacol Res; 2003 Jun; 47(6):523-6. PubMed ID: 12742006
    [No Abstract]   [Full Text] [Related]  

  • 35. [Contribution to coronary therapy].
    Kappen P
    Z Allgemeinmed; 1969 Jan; 45(2):75-8. PubMed ID: 5802029
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hemodynamic effect of intensain].
    Suzuki K; Yasuda K; Takeya K; Kumagaya Y; Yoshida T
    Masui; 1969 Aug; 18(8):740-4. PubMed ID: 5389114
    [No Abstract]   [Full Text] [Related]  

  • 37. [On the effectiveness of orally administered coronary dilator agents].
    Rudolph W; Brand E; Dietze G; Wicklmayr M
    Verh Dtsch Ges Inn Med; 1968; 74():1031-5. PubMed ID: 5714231
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of Intensain on lipid and carbohydrate metabolism].
    Hammerl H; Kränzl C; Nebosis G; Pichler O; Studlar M
    Med Klin; 1969 Dec; 64(51):2382-5. PubMed ID: 5381208
    [No Abstract]   [Full Text] [Related]  

  • 39. [On the effect of propranolol on the effort electrocardiogram in normal, hypersympathotonic, coronary and pericarditis patients].
    Cherchi A; Lixi M; Raffo M; Porrazzo G; Bina M; Camoglio E; Verona F
    Boll Soc Ital Cardiol; 1967; 12(6):587-97. PubMed ID: 5608615
    [No Abstract]   [Full Text] [Related]  

  • 40. Rac-flurbiprofen is more ulcerogenic than its (S)-enantiomer.
    Wechter WJ; Bigornia AE; Murray ED; Levine BH; Young JW
    Chirality; 1993; 5(7):492-4. PubMed ID: 8240924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.